Publications by authors named "Keshab Sil"
Article Synopsis
- COVID-19-associated mucormycosis (CAM) is a new complication noted in kidney transplant recipients, with a 4.4% incidence rate and a significant mortality rate of 26.2% among those affected.
- The study was conducted across 18 centers in India, analyzing cases from November 2020 to July 2021, revealing that older age, obesity, and the need for high-flow oxygen were linked to higher mortality.
- This research highlights the serious risks of CAM in patients with severe COVID-19, particularly emphasizing the high mortality rates in pulmonary cases and aiming to improve understanding and management of this condition.
Article Synopsis
- A study in India assessed early COVID-19 incidence in kidney transplant recipients (KTR) and found that 2.6% experienced COVID-19 within 30 days post-transplant, among 838 performed from March 2020 to May 2021.
- Among the 22 KTR patients with early COVID-19, symptoms varied from asymptomatic to severe, with common symptoms including shortness of breath and loss of smell; their mortality rate was not significantly higher than the overall KTR group.
- The findings indicate a greater severity and mortality in COVID-19 among waitlisted patients compared to KTR, suggesting that KTR may have better outcomes, which could inform decisions regarding
Objectives: There is scarcity of data on reoccurrence of SARS-CoV-2 infections in kidney transplant recipients.
Materials And Methods: We conducted a retrospective multicenter cohort study and identified 13 kidney transplant recipients (10 living and 3 deceased donors) with recurrent COVID-19, and here we report demographics, immunosuppression regimens, clinical profiles, treatments, and outcomes.
Results: COVID-19 second infection rate was 0.
Introduction: Tunneled cuffed catheters (TCC) provides a short and intermediate-term access solution for dialysis patients who fail to get an arteriovenous fistula (AVF). They are associated with high morbidity and mortality along with high rates of infectious complications.
Methods: We present a single-center prospective cohort of 159 TCCs inserted over one year.